HLA-A*0201 Restricted Peptide Vaccine Therapy With Gemcitabine With Gemcitabine in Patient Pancreatic Cancer (Phase1)

NCT01266720 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

BIOLOGICAL: VEGFR1, VEGFR2
DRUG: Gemcitabine

Sponsor

Fukushima Medical University

Collaborators

[object Object]